FMC Earnings

FMC reported its earnings on 2026-02-04, showcasing a revenue of 1.08B against an estimate of 1.15B, resulting in a -5.8% surprise. The EPS was 1.2, surpassing the expected 1.21 by -0.83% . The stock experienced a -19.54% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following FMC's earnings announcement on 2026-02-04, the stock price moved by -19.54% on the day of the release. Over the subsequent five days, it saw a % change. Historically, FMC's stock price tends to shift by an average of -0.18% in the 10 days leading up to earnings and -14.06% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate FMC’s annual revenue to reach 794.80M, while the EPS is projected at 0.13. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.01% and EPS estimates Revise Downward by -0.25% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between FMC's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -0.01%, while EPS estimates moved Revise Downward by -0.25% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, FMC's stock price typically moves by -0.18% in the 10 days before its earnings and -14.06% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.13 and revenue of 794.80M.

The earnings call summary reveals several concerning factors: a decline in adjusted EBITDA and EPS, reduced free cash flow guidance, and a significant dividend cut. The Q&A session highlights uncertainties, such as potential company sale and unclear management responses. Although there are plans for cost reduction and a new product pipeline, the immediate financial outlook is weak, with competitive pricing pressures and declining sales in key areas. These factors, combined with the strategic review and potential sale, suggest a negative sentiment and likely stock price decline.